SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SkinHealth Systems Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.55−0.01 (-0.09%)
Close on Oct 19, 2026
- Market cap
- $1.37B
- P/E (TTM)
- –
- Dividend yield
- –
SkinHealth Systems statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Market Cap | $1.37B | $230.55M |
| Enterprise Value | $1.17B | $202.97M |
| PS Ratio | 4.73 | 3.10 |
| PB Ratio | 24.71 | 3.04 |
| P/FCF Ratio | 64.94 | 27.30 |
| P/OCF Ratio | 62.52 | 22.47 |
Enterprise value
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| EV / Sales | 4.02 | 2.91 |
| EV / FCF | 55.19 | 27.89 |
Income (trailing twelve months)
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Revenue | $290.05M | $102.39M |
| Gross Profit | $192.45M | $60.36M |
| Operating Income | -$4.31M | -$4.31M |
| Pretax Income | -$23.73M | -$2.37M |
| Net Income | -$28.43M | -$6.57M |
| EBITDA | -$4.31M | -$1.98M |
| EPS (Diluted) | -$0.22 | -$0.08 |
Margins
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Gross Margin | 66.4% | 55.2% |
| Operating Margin | -1.49% | -6.04% |
| Pretax Margin | -8.18% | -4.11% |
| Profit Margin | -9.80% | -10.5% |
| EBITDA Margin | -1.49% | -2.67% |
| FCF Margin | 7.29% | 0.02% |
Returns
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Return on Equity (ROE) | -43.9% | -18.2% |
| Return on Assets (ROA) | -5.72% | -13.3% |
| Return on Capital Employed (ROCE) | -1.35% | -9.07% |
Growth
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -6.46% | 8.85% |
| FCF Growth (YoY) | -46.1% | 9.68% |
| Revenue Growth (3Y CAGR) | -6.32% | 7.08% |
| Revenue Growth (5Y CAGR) | 20.4% | 11.8% |
Balance sheet
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $206.07M | $36.66M |
| Net Cash (Debt) | $206.07M | $3.92M |
| Net Cash Per Share | $1.58 | $0.28 |
| Equity (Book Value) | $55.57M | $55.33M |
| Book Value Per Share | $0.43 | $2.87 |
| Tangible Book Value | -$101.00M | $10.79M |
| Working Capital | $127.04M | $56.72M |
Financial position
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Current Ratio | 1.76 | 2.48 |
| Quick Ratio | 1.33 | 1.53 |
| Interest Coverage | -0.17 | -1.85 |
Cash flow (trailing twelve months)
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Operating Cash Flow | $21.96M | -$566.22K |
| Capital Expenditures | -$817.00K | -$3.69M |
| Free Cash Flow | $21.14M | -$696.00K |
| FCF Per Share | $0.16 | -$0.02 |
Efficiency
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Asset Turnover | 0.58 | 0.58 |
| Inventory Turnover | 1.84 | 2.21 |
| Revenue Per Employee | $473.16K | $322.92K |
| Profits Per Employee | -$46.39K | -$51.88K |
| Employee Count | 613 | 185 |
Dividends and yields
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Earnings Yield | -2.07% | -6.88% |
| FCF Yield | 1.54% | -0.45% |
Shares
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Shares Outstanding | 130,141,000 | 44,302,700 |
| Shares Change (YoY) | -2.30% | 3.36% |
| Shares Change (QoQ) | 0.74% | 0.27% |
| Float | 72,560,200 | 37,462,700 |
| Shares Held by Insiders | 44.2% | 10.5% |
| Shares Held by Institutions | 51.6% | 63.5% |
Taxes
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Income Tax | $4.71M | $1.52M |
Scores
| Measure | SkinHealth Systems | Industry median |
|---|---|---|
| Altman Z-Score | 1.28 | 1.95 |
| Piotroski F-Score | 7 | 5 |
Calculated by StockData from SkinHealth Systems's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.